Indeed, the SLE1 subgroup displayed LAIR1 expression similar to HD, whereas the SLE2 group, that includes the majority of SLE patients, showed a low level of LAIR1 expression and a high fraction of CD20+LAIR1− B cells. This evidence concerns the gene LAIR1 and systemic lupus erythematosus.